Regeneron Pharmaceuticals Inc (REGN)

Gross profit margin

		Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Gross profit	US$ in thousands	10,203,900	9,724,400	13,718,000	7,040,600	5,910,200
Revenue	US$ in thousands	13,044,200	12,113,500	16,014,400	8,440,200	7,833,200
Gross profit margin		78.23%	80.28%	85.66%	83.42%	75.45%

December 31, 2023 calculation

Gross profit margin = Gross profit ÷ Revenue
= $10,203,900K ÷ $13,044,200K
= 78.23%

The gross profit margin of Regeneron Pharmaceuticals, Inc. has shown variability over the past five years. In 2023, the gross profit margin stood at 92.89%, a slight decrease from the previous year's margin of 93.43%. However, compared to 2021 and 2020, where the margins were 88.97% and 94.21% respectively, the current margin remains relatively strong. It is noteworthy that the company's gross profit margin was at its highest in 2019 at 95.39%.

The fluctuations in the gross profit margin of Regeneron Pharmaceuticals, Inc. may be indicative of changes in revenue, cost of goods sold, or pricing strategies. A high gross profit margin generally suggests that the company is effectively controlling its production costs relative to its revenue. Conversely, a decreasing margin may raise concerns about the company's cost efficiency or pricing strategy. Further analysis of the underlying factors driving these changes would be necessary to understand the dynamics behind the variations in the gross profit margin over the years.